Freeport-McMoRan Inc. press release

CLASS ACTION UPDATE for AFIB, BFLY and MP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

2022-04-14

NYSE - New York Stock Exchange · Copper · Gold · Molybdenum · United States

NEW YORK, NY / ACCESSWIRE / April 14, 2022 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

AFIB Shareholders Click Here: https://www.zlk.com/pslra-1/acutus-medical-inc-loss-submission-form?prid=25952&wire=1 BFLY Shareholders Click Here: https://www.zlk.com/pslra-1/butterfly-network-inc-loss-submission-form?prid=25952&wire=1 MP Shareholders Click Here: https://www.zlk.com/pslra-1/mp-materials-corp-f-k-a-fortress-value-acquisition-corp-loss-submission-form?prid=25952&wire=1

ADDITIONAL INFORMATION BELOW

Acutus Medical, Inc. (NASDAQ:AFIB)

This lawsuit is on behalf of all purchasers of Acutus common stock between May 13, 2021 and November 11, 2021, inclusive. Lead Plaintiff Deadline : April 18, 2022 TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/acutus-medical-inc-loss-submission-form?prid=25952&wire=1

According to the filed complaint, (a) a material percentage of the Company's AcQMap imaging and mapping systems under evaluation had been randomly installed at sites with little, if any, consideration given to whether the healthcare providers at the selected locations were likely to adopt, or desire, the Company's products; (b) a material percentage of the AcQMap systems under evaluation had been installed in locations where the Company did not possess the infrastructure necessary to appropriately educate, train, and support medical service providers on the system's operations; (c) as a result of (a) and (b) above, defendants were in the process of designing a strategic plan to terminate and relocate approximately 20% of then-existing AcQMap systems evaluation arrangements; (d) the Company's management discussion and analysis was materially false and misleading and failed to disclose that the termination and relocation of approximately 20% of existing AcQMap systems evaluation arrangements was reasonably likely to have a material adverse effect on the Company's 2021 financial results; and (e) the Company's risk factor discussions were materially false and misleading and made reference to potential risks without disclosing that such risks were then-existing or adequately describing the specific nature of the risks then facing the Company.

Butterfly Network, Inc. f/k/a Longview Acquisition Corp. (NYSE:BFLY)

This lawsuit is one behalf of: (a) all persons or entities that purchased or otherwise acquired Butterfly securities between February 16, 2021 and November 15, 2021, both dates inclusive and/or (b) all holders of Butterfly common stock as of the record date for the special meeting of shareholders held on February 12, 2021 to consider approval of the merger between Longview Acquisition Corp. and Butterfly. Lead Plaintiff Deadline : April 18, 2022 TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/butterfly-network-inc-loss-submission-form?prid=25952&wire=1

According to the filed complaint, (i) Butterfly had overstated its post-merger business and financial prospects; (ii) notwithstanding the ongoing COVID-19 pandemic, Butterfly's financial projections failed to take into account the pandemic's broad consequences, which included healthcare logistical challenges, and medical personnel fatigue; (iii) accordingly, Butterfly's gross margin levels and revenue projections were less sustainable than the Company had represented; (iv) all the foregoing was reasonably likely to have a material negative impact on Butterfly's business and financial condition; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

MP Materials Corp. f/k/a Fortress Value Acquisition Corp. (NYSE:MP)

MP Lawsuit on behalf of:investors who purchased May 1, 2020 - February 2, 2022 Lead Plaintiff Deadline : April 25, 2022 TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/mp-materials-corp-f-k-a-fortress-value-acquisition-corp-loss-submission-form?prid=25952&wire=1

According to the filed complaint, during the class period, MP Materials Corp. f/k/a Fortress Value Acquisition Corp. made materially false and/or misleading statements and/or failed to disclose that: (i) Fortress Value Acquisition Corp. ("FVAC") had overstated its due diligence efforts and expertise with respect to identifying target companies to acquire; (ii) FVAC performed inadequate due diligence into Legacy MP Materials prior to the business combination, or else ignored significant red flags regarding, inter alia, Legacy MP Materials' management, compliance policies, and Mountain Pass's profitability; (iii) as a result, the Company's future business and financial prospects post-business combination were overstated; (iv) MP Materials engaged in an abusive transfer price manipulation scheme with a related party in the People's Republic of China to artificially inflate the Company's profits; (v) MP Materials' ore at the Mountain Pass Rare Earth Mine and Processing Facility was not economically viable to harvest for rare earth metals; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff.Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP Joseph E. Levi, Esq. Eduard Korsinsky, Esq. 55 Broadway, 10th Floor New York, NY 10006 jlevi@levikorsinsky.com Tel: (212) 363-7500 Fax: (212) 363-7171 www.zlk.com

SOURCE: Levi & Korsinsky, LLP

View source version on accesswire.com: https://www.accesswire.com/697494/CLASS-ACTION-UPDATE-for-AFIB-BFLY-and-MP-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders